Notably, our group and others have previously demonstrated that Shh pathway is associated with resistance to several anti-tumor therapies [26] such as chemotherapy [27,28], Tyrosine Kinase Inhibitors (TKIs) [29] and radiotherapy [30]. Here, SHH is linked to neoplasm.